|
1
|
Rosell R, de las Peñas R, Balaña C,
Santarpia M, Salazar F, de Aguirre I, Reguart N, Villa S, Wei J,
Ramirez JL, et al: Translational research in glioblastoma
multiforme: Molecular criteria for patient selection. Futur Oncol.
4:219–228. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mikkelsen VE, Solheim O, Salvesen Ø and
Torp SH: The histological representativeness of glioblastoma tissue
samples. Acta Neurochir (Wien). 163:1911–1920. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iacob G and Dinca EB: Current data and
strategy in glioblastoma multiforme. J Med Life. 2:386–393.
2009.PubMed/NCBI
|
|
5
|
Nakada M, Kita D, Watanabe T, Hayashi Y,
Teng L, Pyko IV and Hamada J: Aberrant signaling pathways in
glioma. Cancers (Basel). 3:3242–3278. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Szopa W, Burley TA, Kramer-Marek G and
Kaspera W: Diagnostic and therapeutic biomarkers in glioblastoma:
Current status and future perspectives. Biomed Res Int.
2017:80135752017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cancer Genome Atlas Research Network, .
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vanhaesebroeck B, Guillermet-Guibert J,
Graupera M and Bilanges B: The emerging mechanisms of
isoform-specific PI3K signalling. Nat Rev Mol Cell Biol.
11:329–341. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moscatello DK, Holgado-Madruga M, Emlet
DR, Montgomery RB and Wong AJ: Constitutive activation of
phosphatidylinositol 3-kinase by a naturally occurring mutant
epidermal growth factor receptor. J Biol Chem. 273:200–206. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suk HS, Hromas R and Lee SH: Emerging
features of DNA double-strand break repair in humans. New Research
Directions in DNA Repair; 2013, View
Article : Google Scholar
|
|
11
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: Its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Auger KR, Serunian LA, Soltoff SP, Libby P
and Cantley LC: PDGF-dependent tyrosine phosphorylation stimulates
production of novel polyphosphoinositides in intact cells. Cell.
57:167–175. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ruderman NB, Kapeller R, White MF and
Cantley LC: Activation of phosphatidylinositol 3-kinase by insulin.
Proc Natl Acad Sci USA. 87:1411–1415. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Crespo S, Kind M and Arcaro A: The role of
the PI3K/AKT/mTOR pathway in brain tumor metastasis. J Cancer
Metastasis Treat. 2:80–89. 2016. View Article : Google Scholar
|
|
15
|
Liu Y, Zheng J, Zhang Y, Wang Z, Yang Y,
Bai M and Dai Y: Fucoxanthin activates apoptosis via inhibition of
PI3K/Akt/mTOR pathway and suppresses invasion and migration by
restriction of p38-MMP-2/9 pathway in human glioblastoma cells.
Neurochem Res. 41:2728–2751. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo SM, Tsai WC, Tsai CK, Chen Y and Hueng
DY: ARID4B knockdown suppresses PI3K/AKT signaling and induces
apoptosis in human glioma cells. Onco Targets Ther. 14:1843–1855.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gonçalves CS, Lourenço T, Xavier-magalhães
A, Pojo M and Costa BM: Mechanisms of aggressiveness in
glioblastoma: Prognostic and potential therapeutic insights.
Evolution of the Molecular Biology of Brain Tumors and the
Therapeutic Implications; 2013
|
|
18
|
Ray SK: Glioblastoma: Molecular Mechanisms
of Pathogenesis and Current Therapeutic Strategies. 1st edition.
Springer; New York, NY: pp. pp4312010
|
|
19
|
Kashyap D, Garg VK and Goel N: Intrinsic
and extrinsic pathways of apoptosis: Role in cancer development and
prognosis. Advances in Protein Chemistry and Structural Biology.
1st edition. Vol 125. Elsevier Inc.; pp. 73–120. 2021, View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brentnall M, Rodriguez-menocal L, De
Guevara RL, Cepero E and Boise LH: Caspase-9, caspase-3 and
caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell
Biol. 14:322013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Obeng E: Apoptosis (programmed cell death)
and its signals-a review. Braz J Biol. 81:1133–1143. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eskandari E and Eaves CJ: Paradoxical
roles of caspase-3 in regulating cell survival, proliferation, and
tumorigenesis. J Cell Biol. 221:e2022011592022.PubMed/NCBI
|
|
23
|
Yang X, Zhong DN, Qin H, Wu PR, Wei KL,
Chen G, He RQ and Zhong JC: Caspase-3 over-expression is associated
with poor overall survival and clinicopathological parameters in
breast cancer: A meta-analysis of 3091 cases. Oncotarget.
9:8629–8641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang KH, Fang WL, Li AFY, Liang PH, Wu
CW, Shyr YM and Yang MH: Caspase-3, a key apoptotic protein, as a
prognostic marker in gastric cancer after curative surgery. Int J
Surg. 52:258–263. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Andressakis D, Lazaris AC, Tsiambas E,
Kavantzas N, Rapidis A and Patsouris E: Evaluation of caspase-3 and
caspase-8 deregulation in tongue squamous cell carcinoma, based on
immunohistochemistry and computerised image analysis. J Laryngol
Otol. 122:1213–1218. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin YF, Lai TC, Chang CK, Chen CL, Huang
MS, Yang CJ, Liu HG, Dong JJ, Chou YA, Teng KH, et al: Targeting
the XIAP/caspase-7 complex selectively kills caspase-3-deficient
malignancies. J Clin Invest. 123:3861–3875. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vítor AC, Huertas P, Legube G and de
Almeida SF: Studying DNA double-strand break repair: An
ever-growing toolbox. Front Mol Biosci. 7:242020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khanna KK and Jackson SP: DNA
double-strand breaks: Signaling, repair and the cancer connection.
Nat Genet. 27:247–254. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mladenov E and Iliakis G: The pathways of
double-strand break repair. DNA Repair-On the Pathways to Fixing
DNA Damage and Errors. 2011. View
Article : Google Scholar
|
|
30
|
Srivastava M and Raghavan SC: DNA
double-strand break repair inhibitors as cancer therapeutics. Chem
Biol. 22:17–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mladenov E, Magin S, Soni A and Iliakis G:
DNA double-strand-break repair in higher eukaryotes and its role in
genomic instability and cancer: Cell cycle and
proliferation-dependent regulation. Semin Cancer Biol. 37–38.
51–64. 2016.PubMed/NCBI
|
|
32
|
Swift LH and Golsteyn RM: Genotoxic
anti-cancer agents and their relationship to DNA damage, mitosis,
and checkpoint adaptation in proliferating cancer cells. Int J Mol
Sci. 15:3403–3431. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harper JW and Elledge SJ: The DNA damage
response: Ten years after. Mol Cell. 28:739–745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rogakou EP, Pilch DR, Orr AH, Ivanova VS
and Bonner WM: DNA double-stranded breaks induce histone H2AX
phosphorylation on serine 139. J Biol Chem. 273:5858–5868. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Redon C, Pilch D, Rogakou E, Sedelnikova
O, Newrock K and Bonner W: Histone H2A variants H2AX and H2AZ. Curr
Opin Genet Dev. 12:162–169. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bonner WM, Redon CE, Dickey JS, Nakamura
AJ, Sedelnikova OA, Solier S and Pommier Y: GammaH2AX and cancer.
Nat Rev Cancer. 8:957–967. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dickey JS, Redon CE, Nakamura AJ, Baird
BJ, Sedelnikova OA and Bonner WM: H2AX: Functional roles and
potential applications. Chromosoma. 118:683–692. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Redon CE, Nakamura AJ, Martin OA, Parekh
PR, Weyemi US and Bonner WM: Recent developments in the use of
γ-H2AX as a quantitative DNA double-strand break biomarker. Aging
(Albany NY). 3:168–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sedelnikova OA and Bonner WM: GammaH2AX in
cancer cells: A potential biomarker for cancer diagnostics,
prediction and recurrence. Cell Cycle. 5:2909–2913. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Matthaios D, Foukas PG, Kefala M, Hountis
P, Trypsianis G, Panayiotides IG, Chatzaki E, Pantelidaki E, Bouros
D, Karakitsos P and Kakolyris S: γ-H2AX expression detected by
immunohistochemistry correlates with prognosis in early operable
non-small cell lung cancer. Onco Targets Ther. 5:309–314. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gorgoulis VG, Vassiliou LVF, Karakaidos P,
Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr,
Kastrinakis NG, Levy B, et al: Activation of the DNA damage
checkpoint and genomic instability in human precancerous lesions.
Nature. 434:907–913. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu X, Li F, Huang Q, Zhang Z, Zhou L,
Deng Y, Zhou M, Fleenor DE, Wang H, Kastan MB and Li CY:
Self-inflicted DNA double-strand breaks sustain tumorigenicity and
stemness of cancer cells. Cell Res. 27:764–783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ray SK, Patel SJ, Welsh CT, Wilford GG,
Hogan EL and Banik NL: Molecular evidence of apoptotic death in
malignant brain tumors including glioblastoma multiforme:
Upregulation of calpain and caspase-3. J Neurosci Res. 69:197–206.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tirapelli LF, Bolini PH, Tirapelli DP,
Peria FM, Becker AN, Saggioro FP and Carlotti CG Jr: Caspase-3 and
Bcl-2 expression in glioblastoma: An immunohistochemical study. Arq
Neuropsiquiatr. 68:603–607. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
San Filippo J, Sung P and Klein H:
Mechanism of eukaryotic homologous recombination. Annu Rev Biochem.
77:229–257. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lieber MR, Ma Y, Pannicke U and Schwarz K:
Mechanism and regulation of human non-homologous DNA end-joining.
Nat Rev Mol Cell Biol. 4:712–720. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Turgeon MO, Perry NJS and Poulogiannis G:
DNA damage, repair, and cancer metabolism. Front Oncol. 8:152018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bernstein C, Prasad RA, Nfonsam V and
Bernstei H: DNA damage, DNA repair and cancer. New Research
Directions in DNA Repair; 2013, View
Article : Google Scholar
|
|
49
|
Castedo M, Ferri KF and Kroemer G:
Mammalian target of rapamycin (mTOR): Pro- and anti-apoptotic. Cell
Death Differ. 9:99–100. 2002. View Article : Google Scholar : PubMed/NCBI
|
